Engineering and Development

Management and Executive

Product Management

Chief Executive Officer (CEO)

Chief Financial Officer

Tempus Acquiring Pharmacogenetics Assets of Recently Defunct OneOme

Tempus AI Prepared for Reimbursement, FDA Tailwinds in 2026 as Q3 Revenues Climb 85 Percent

Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity

Tempus AI Shares Are Trading Higher Monday: What's Going On?

Variant Assessment Scientist I/II – Rare Disease: Exome/Genome

Ambry Genetics is a CAP-accredited and CLIA-licensed molecular genetics laboratory dedicated to understanding and treating human diseases through genetics. The Variant Assessment Scientist I/II will be responsible for variant analysis of diagnostic molecular genetic test results, writing research articles, and collaborating with other medical professionals to provide thorough clinical interpretations.

Variant Assessment Scientist I/II – Rare Disease: Exome/Genome (REMOTE, USA)

Senior Talent Acquisition Partner

Senior Director of Statistical Genetics

Clinical Genomics Scientist II

Clinical Genomic Scientist II

Clinical Genomic Scientist

Sign up with Google

Sign in with Google